Hearing improvement after bevacizumab for neurofibromatosis type 2. The New England journal of medicine [N Engl J Med] Journal article

Title	Hearing improvement after bevacizumab for neurofibromatosis type 2.
Author(s)	Diao JS, Xia WS, Guo SZ
Source	N Engl J Med 2009 Oct 29; 361(18):1810; author reply 1810-1.
MeSH	Angiogenesis Inhibitors Antibodies, Monoclonal Hearing Loss Humans Neurofibromatosis 2 Neuroma, Acoustic Vascular Endothelial Growth Factor A
Language	eng
Pub Type(s)	Comment Letter
PubMed ID	19877310

Advertise on this site.